Emerald Mutual Fund Advisers Trust Kal Vista Pharmaceuticals, Inc. Transaction History
Emerald Mutual Fund Advisers Trust
- $1.23 Billion
- Q1 2025
A detailed history of Emerald Mutual Fund Advisers Trust transactions in Kal Vista Pharmaceuticals, Inc. stock. As of the latest transaction made, Emerald Mutual Fund Advisers Trust holds 608,213 shares of KALV stock, worth $8.25 Million. This represents 0.57% of its overall portfolio holdings.
Number of Shares
608,213
Previous 549,688
10.65%
Holding current value
$8.25 Million
Previous $4.66 Million
50.76%
% of portfolio
0.57%
Previous 0.32%
Shares
8 transactions
Others Institutions Holding KALV
# of Institutions
140Shares Held
54.4MCall Options Held
1.38MPut Options Held
6K-
Vr Adviser, LLC New York, NY6.7MShares$91 Million18.68% of portfolio
-
Tang Capital Management LLC San Diego, CA4.94MShares$67.1 Million3.7% of portfolio
-
Suvretta Capital Management, LLC New York, NY4.91MShares$66.7 Million2.48% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA4.89MShares$66.3 Million3.55% of portfolio
-
Vestal Point Capital, LP New York, NY4.75MShares$64.5 Million3.92% of portfolio
About KalVista Pharmaceuticals, Inc.
- Ticker KALV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,602,000
- Market Cap $334M
- Description
- KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...